Unity Cures Future (UCF) Biobank

Unity Cures Future (UCF) Biobank for Translational & Biomedical Research At UCF College of Medicine and Burnett School of Biomedical Sciences with Identifiable Human Tissue.

Research scientists of the University of Central Florida College of Medicine (COM) and Burnett School of Biomedical Sciences (BSBS) conduct laboratory studies in biomedical and translational medical research for the purpose of understanding human disease and developing innovative methods for diagnosing, measuring, or treating disease or disease symptoms. The key research divisions are cancer, cardiovascular, immunity and pathogenesis, neuroscience, and molecular microbiology.

Study Overview

• Status: Recruiting
• Conditions: Tissue Banking

Detailed Description

The goal of this human tissue repository protocol is to aggregate resources and streamline the acquisition of human tissue. It is optimal for the advancement of biomedical and translational medical research that the human tissue be received under one protocol by the College of Medicine's the Clinical & Aerospace Health Research team and transferred to the COM/BSBS research scientists for laboratory testing.

This aggregation of efforts and resources through a human tissue repository protocol allows for:

1. Improvements in biomedical and translational medical research by availability of viable human tissues.
2. Reduced recruitment and enrollment burden on the Clinical & Aerospace Health Research team and the participants via pooled recruitment. Further, participants will only need to provide one informed consent. Received human tissue may be used for multiple protocols.
3. Improved data for analysis as participants will complete an online case report form containing basic demographic data; planned location and date of upcoming surgery or procedure; diagnosis; name of surgeon/doctor for the planned surgery or procedure; type of surgery or procedure; medical data; medical history; and surgery history.

• Study Type: Observational
• Enrollment (Estimated): 10000

Contacts and Locations

• Study Contact: Name: Britney-Ann Wray, BS, CTBS, CCRP; Phone Number: 4072668742; Email: britney-ann.wray@ucf.edu

Study Locations

• United States
  • Florida
    • Orlando, Florida, United States, 32827
      • Recruiting
      • University of Central Florida
      • Contact: Amoy Fraser, PhD, CCRP, PMP; Phone Number: 4072668742; Email: Amoy.Fraser@UCF.edu
      • Contact: Amoy Fraser, PhD, CCRP, PMP
      • Contact: Britney-Ann Wray, BS, CTBS, CCRP; Phone Number: 4072668742; Email: britney-ann.wray@ucf.edu

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: Adult; Older Adult
• Accepts Healthy Volunteers: Yes

• Sampling Method: Non-Probability Sample

Study Population

Participants will donate unwanted human tissue as a result of surgery.

Description

Inclusion Criteria:

1. be able to read and understand English
2. scheduled for a surgery or procedure that will result in the removal of human tissue.

Exclusion Criteria:

1. Pregnant
2. unable to provide an informed consent
3. unable to understand or read in English
4. minors (ages under 18)
5. prisoners

Study Plan

How is the study designed?

Number of groups / cohorts

1

Cohorts and Interventions

Group / Cohort

Donated Human Tissue; This Project will receive discarded human tissue from consented participants. For the purposes of this project, human tissue is defined as any bodily material collected from a human person, including bone marrow, skin, tumors, etc., through a clinical procedure. The clinical procedure will done not be done solely for the purpose of this Project. Participants (donors) will prospectively provide informed consent, complete an online case report form, and donate the unwanted human tissue that results from their surgery/procedure.

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Receipt of donated human tissue for research	The key research divisions are cancer, cardiovascular, immunity and pathogenesis, neuroscience, and molecular microbiology. Frequently, these studies require human tissue for testing of assays and devices.	50 years

Collaborators and Investigators

• Sponsor: University of Central Florida

Study record dates

Study Major Dates

• Study Start (Actual): November 6, 2024
• Primary Completion (Estimated): November 6, 2075
• Study Completion (Estimated): November 6, 2075

Study Registration Dates

• First Submitted: January 13, 2025
• First Submitted That Met QC Criteria: January 13, 2025
• First Posted (Actual): March 25, 2025

Study Record Updates

• Last Update Posted (Actual): March 25, 2025
• Last Update Submitted That Met QC Criteria: January 13, 2025
• Last Verified: January 1, 2025

More Information

Terms related to this study

• Keywords: surgery; biobank; tissue; donate
• Other Study ID Numbers: STUDY00007256

Drug and device information, study documents

• Studies a U.S. FDA-regulated drug product: No
• Studies a U.S. FDA-regulated device product: No
• product manufactured in and exported from the U.S.: No